Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...

Piper Sandler restated their overweight rating on shares of Intapp (NASDAQ:INTA – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. Piper Sandler currently has a ...

Piper Sandler raised the firm’s price target on Kemper (KMPR) to $86 from $83 and keeps an Overweight rating on the shares following quarterly ...

Simon Property Group (NYSE:SPG – Get Free Report) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research report issued on Wednesday, MarketBeat.com ...

Piper Sandler adjusted its financial outlook for Amazon.com (NASDAQ:AMZN), increasing the price target to $265 from the previous $225, while maintaining an Overweight rating on the company's shares.

Piper Sandler's research dated Feb. 4 has revealed a less optimistic outlook for Meta Platforms' position in the artificial intelligence race.

He noted that advisory services accounted for over half of firmwide net revenues for the fourth consecutive year. Abraham stated that the company completed the acquisition of Aviditi Advisors, ...

In a report released today, David Amsellem from Piper Sandler maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Investing.com -- Piper Sandler analysts see Tesla (NASDAQ: TSLA) as "one of the most defensive stocks" in the auto sector ...